Conversely, administration of agonist anti-CD40 mAb to LNG-treated mice at dpi 1 produced Chlamydia burden and pulmonary inflammation at 12 dpi that closely resembled that seen in placebo-pelleted controls. This evidence concerns the gene CD40 and inflammatory response.